Omega Healthcare Investors, Inc. (NYSE:OHI) Shares Sold by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company reduced its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 0.2% in the 3rd quarter, Holdings Channel.com reports. The fund owned 239,094 shares of the real estate investment trust’s stock after selling 370 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Omega Healthcare Investors were worth $9,731,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of OHI. Bank of Montreal Can grew its stake in Omega Healthcare Investors by 309.7% in the third quarter. Bank of Montreal Can now owns 267,394 shares of the real estate investment trust’s stock worth $10,784,000 after purchasing an additional 202,131 shares in the last quarter. Truvestments Capital LLC bought a new position in Omega Healthcare Investors during the 3rd quarter worth approximately $43,000. Loomis Sayles & Co. L P acquired a new position in shares of Omega Healthcare Investors in the 3rd quarter worth approximately $47,000. Dynamic Technology Lab Private Ltd bought a new stake in shares of Omega Healthcare Investors in the 3rd quarter valued at approximately $299,000. Finally, Daiwa Securities Group Inc. raised its position in shares of Omega Healthcare Investors by 317.7% during the 3rd quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust’s stock valued at $160,739,000 after acquiring an additional 3,003,845 shares in the last quarter. Institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Price Performance

Shares of NYSE OHI opened at $39.54 on Wednesday. The stock has a market cap of $10.67 billion, a P/E ratio of 29.07, a P/E/G ratio of 1.24 and a beta of 0.98. The firm’s 50-day simple moving average is $40.56 and its 200 day simple moving average is $37.53. Omega Healthcare Investors, Inc. has a fifty-two week low of $27.53 and a fifty-two week high of $44.42. The company has a quick ratio of 6.48, a current ratio of 6.48 and a debt-to-equity ratio of 1.10.

Omega Healthcare Investors Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Monday, November 4th were paid a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.78%. The ex-dividend date was Monday, November 4th. Omega Healthcare Investors’s dividend payout ratio is currently 197.06%.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. BNP Paribas raised shares of Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price objective for the company in a report on Thursday, October 31st. Scotiabank boosted their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a research report on Monday, August 26th. BMO Capital Markets raised their target price on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a “market perform” rating in a report on Monday, October 7th. Truist Financial upped their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a report on Wednesday, September 4th. Finally, Berenberg Bank initiated coverage on Omega Healthcare Investors in a research report on Friday, October 18th. They set a “buy” rating and a $45.00 price objective for the company. Seven analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, Omega Healthcare Investors presently has an average rating of “Hold” and a consensus price target of $40.00.

Insider Activity

In related news, COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the transaction, the chief operating officer now directly owns 100,000 shares of the company’s stock, valued at $4,025,000. The trade was a 36.19 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Robert O. Stephenson sold 22,542 shares of the business’s stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the sale, the chief financial officer now owns 183,076 shares in the company, valued at approximately $7,357,824.44. This trade represents a 10.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.37% of the company’s stock.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.